Search

Your search keyword '"Zarei, Mohammad"' showing total 1,874 results
Start Over Author "Zarei, Mohammad"
1,874 results on '"Zarei, Mohammad"'

205. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

Author

Zhang, Meijian, primary, Barroso, Emma, additional, Ruart, Maria, additional, Peña, Lucía, additional, Peyman, Mona, additional, Aguilar-Recarte, David, additional, Montori-Grau, Marta, additional, Rada, Patricia, additional, Cugat, Clara, additional, Montironi, Carla, additional, Zarei, Mohammad, additional, Jurado-Aguilar, Javier, additional, Camins, Antoni, additional, Balsinde, Jesús, additional, Valverde, Ángela M., additional, Wahli, Walter, additional, Palomer, Xavier, additional, and Vázquez-Carrera, Manuel, additional

Published
2023
Full Text
View/download PDF

206. Toxicity of arsenic on isolated human lymphocytes: The key role of cytokines and intracellular calcium enhancement in arsenic-induced cell death

Author

Zarei Mohammad Hadi, Pourahmad Jalal, and Nassireslami Ehsan

Subjects
arsenic, cytotoxicity, reactive oxygen species (ros), isolated human lymphocyte, mitochondrial membrane potential, intracellular calcium, Chemistry, QD1-999
Abstract

Arsenic (As) is a semi-metal which causes health problems in human, and immune system has been documented as one of the main target of arsenic toxicity. Apoptosis has a crucial role in regulation of immune system, but it can also have an important role in As immune suppression. So, we decided to assess the comprehensive mechanism of As cytotoxic effect on lymphocytes isolated from human blood. We determine the direct effect of arsenic on human lymphocytes which have a key role in immune system functionality. To evaluate the mechanism of arsenic toxicity on human lymphocytes, we use accelerated cytotoxicity mechanisms screening (ACMS) technique. Lymphocytes were isolated from blood of healthy persons using Ficoll-paque PLUS standard method. Following treatment of human lymphocytes with 0.05-50 μM of arsenic for 12 h, cell viability was measured. For determination of mechanistic parameters, isolated human lymphocytes incubated with 1/2IC5012h (7.5 μM), IC5012h (15 μM) and 2IC5012h (30 μM) for 2, 4 and 6 h. The results of this study demonstrate arsenic-associated apoptosis in human lymphocytes is mainly through enhancement of intracellular calcium which causes oxidative stress and following adverse effect on lymphocytes organelles (like mitochondria and lysosome). Involvement of cellular proteolysis, activation of caspase-3, lipid peroxidation and stimulation of cytokines (IL2, INF-gamma and TNF-alpha) production were also associated with arsenic induced lymphocyte toxicity.

Published
2019
Full Text
View/download PDF

212. Comparison of Intravitreal Bevacizumab and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity

Author

Roohipoor, Ramak, Karkhaneh, Reza, Riazi-Esfahani, Mohammad, Dastjani Farahani, Afsar, Khodabandeh, Alireza, Ebrahimi Adib, Nazanin, Imani, Marjan, Khojasteh Jafari, Hassan, Riazi-Esfahani, Hamid, Hosseinpour, Jamaleddin, Zarei, Mohammad, Ghasemi, Hamed, Mirghorbani, Masoud, Yaseri, Mehdi, Davoudi, Samaneh, and Modjtahedi, Bobeck S.

Published
2018
Full Text
View/download PDF

246. Comparison of low‐level laser therapy and standard treatment for temporomandibular disorders: An assessment of therapeutic and placebo effects.

Author

Chamani, Goli, Zarei, Mohammad Reza, Rad, Maryam, and Mafi, Sahar

Subjects
*JAW physiology, *STATISTICS, *DENTAL clinics, *ANALYSIS of variance, *PHYSICAL therapy, *LASER therapy, *PAIN clinics, *VISUAL analog scale, *TREATMENT effectiveness, *RANDOMIZED controlled trials, *PRE-tests & post-tests, *COMPARATIVE studies, *PLACEBOS, *DESCRIPTIVE statistics, *REPEATED measures design, *BLIND experiment, *RESEARCH funding, *TEMPOROMANDIBULAR disorders, *STATISTICAL sampling, *CONTROL groups, *DATA analysis, *DATA analysis software
Abstract

Background: Despite extensive research on the use of low‐power lasers for TMD treatment, the extent of their effectiveness remains uncertain. Objective: This study aimed to investigate the therapeutic or placebo effect of LLLT for TMD, and to compare it with standard treatment methods. A unique aspect of this study was the inclusion of a control group that received only standard treatment, allowing for an assessment of the placebo effect of LLLT. Methods: A total of 42 patients with TMD were referred to Kerman Dental School Pain Clinic and were randomly assigned to three groups: group A received LLLT, group B was a placebo group and group C was a control group that received only standard treatment. The laser groups received gallium‐aluminium‐arsenide laser treatment twice a week for 10 sessions. Patients' jaw movement rate indicators and VAS index were evaluated at the start of treatment, and indicators were re‐recorded every week for 5 weeks. SPSS 21 was used for statistical analysis, including ANOVA and Tukey's post hoc tests for inter‐group comparisons. The repeated measurement test was used to analyse the data. Results: All groups showed significant improvement in VAS indicators (p =.0001), lateral jaw movements (p =.0001), forward jaw movement (p =.007) but not for maximum mouth opening. No significant difference was observed between the groups at the end of the study (p =.000). Conclusion: Our study provides insights into LLLT's effectiveness for TMD, suggesting it cannot replace standard treatment alone. These findings contribute to the literature and emphasise the importance of including a control group in future studies to assess the placebo effect of LLLT. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results